CSI 2014: Whats New? Revivent TC™ First in Man

First in Man: Revivent TC™ Transcatheter LV Volume Reduction

Prof. Petr Neuzil, MD (Na Homolce Hospital, Prague, Czech Republic)


The Revivent TC™ TransCatheter Ventricular Enhancement System requires regulatory approval and is not yet commercially available.


Transcatheter Treatment of Ischaemic Heart Failure: The Less Invasive Ventricular Enhancement (LIVE™) Procedure Using the Revivent TC™ TransCatheter Ventricular Enhancement System

Join the experts from EuroPCR2014 in Paris to learn more about transcatheter reshaping of the left ventricle for treating the cause of heart failure.

Chairperson

Prof. Horst Sievert (CardioVascular Center, Frankfurt, Germany)

The LIVE™ Procedure, Technology and Techniques

Prof. Olaf Wendler (King’s College Hospital, London, UK)

Revivent™ and Revivent TC™: Clinical Results to Date

Prof. Helge Moellmann (Kerckhoff-Klinik, Bad Nauheim, Germany)

Clinical Case Reports and Identifying the Ideal Patient Candidate for the LIVE™ Procedure

Prof. Petr Neuzil, MD (Na Homolce Hospital, Prague, Czech Republic)